Myriad Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.56

+0.06 (+1.33%)

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 2 13%

Hold 9 56%

Sell 5 31%

Price Target

Analyst Price Target +808.8% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $4.56

Current
$4.56

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

544.5%

Low target

Base Case

$41.44

+808.8%

Avg target

Bull Case

$63.29

+1,287.9%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$8.59

-46.9% from high

52-Week Low

$3.53

+29.2% from low

Target vs 52W High

$41.44

+382.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%